Mireya Suárez-Pérez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mireya Suárez-Pérez has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Ana Gabriela Morachis-Valdez
Laboratorio de Alimentos, Facultad de Química, Unidad Cerrillo, Universidad Autónoma del Estado de México, Carretera Toluca—Ixtlahuaca Kilómetro 15.5, El Cerrillo Piedras Blancas, Toluca C.P. 50000, Mexico
1 shared publication - Angel Santillán-Álvarez
División de Gastronomía, Tecnológico Nacional de México (TecNM), Tecnológico de Estudios Superiores de Valle de Bravo, Km 30 de la Carretera Nacional Federal Monumento-Valle de Bravo, Ejido de San Antonio de La Laguna, Valle de Bravo C.P. 51200, Mexico
1 shared publication - Daniel Díaz-Bandera
Laboratorio de Alimentos y Toxicología Ambiental, Facultad de Química, Universidad Autónoma del Estado de México, Carr. Toluca-Ixtlahuaca Km. 15, El Cerrillo Piedras Blancas, Toluca 50200, Mexico
1 shared publication - Francisco Antonio López-Medina
Laboratorio de Alimentos y Toxicología Ambiental, Facultad de Química, Universidad Autónoma del Estado de México, Carr. Toluca-Ixtlahuaca Km. 15, El Cerrillo Piedras Blancas, Toluca 50200, Mexico
1 shared publication - Gerardo Heredia-García
Laboratorio de Alimentos y Toxicología Ambiental, Facultad de Química, Universidad Autónoma del Estado de México, Carr. Toluca-Ixtlahuaca Km. 15, El Cerrillo Piedras Blancas, Toluca 50200, Mexico
1 shared publication - Guadalupe López-García
Laboratorio de Alimentos y Toxicología Ambiental, Facultad de Química, Universidad Autónoma del Estado de México, Carr. Toluca-Ixtlahuaca Km. 15, El Cerrillo Piedras Blancas, Toluca 50200, Mexico
1 shared publication
Latest Publications
- Open Access
Biopolymeric Delivery Systems Enriched with Melaleuca alternifolia, Mentha piperita, and Polyhydroxy Acids for Acne Management: A Narrative Review
Acne vulgaris is a prevalent inflammatory disorder of the pilosebaceous unit involving follicular hyperkeratinization, altered sebum production, Cutibacterium acnes proliferation, microbiome imbalance, and immune activation. Although antibiotics, retinoids, benzoyl peroxide, and keratolytic agents remain central to clinical management, their long-term use may be limited by irritation, recurrence, adherence issues, and increasing antimicrobial resistance. This narrative review critically evaluates the dermatological relevance of Melaleuca alternifolia tea tree essential oil (TTEO), Mentha piperita peppermint essential oil (PPEO), and polyhydroxy acids (PHAs), as well as their incorporation into biopolymeric delivery systems for acne-oriented topical applications. Following SANRA principles, evidence from clinical, preclinical, ex vivo, and in vitro studies was synthesized, with emphasis on antimicrobial activity, inflammatory modulation, keratolytic and barrier-supportive effects, formulation stability, and release behavior. TTEO shows the strongest clinical support among the reviewed natural bioactives, including reductions in lesion counts and acne severity when applied as conventional or nanoemulsion-based formulations. PPEO is mainly supported by experimental evidence, particularly antimicrobial activity against acne-associated microorganisms, anti-inflammatory potential, and menthol-related neurocutaneous effects, whereas acne-specific clinical validation remains limited. PHAs, particularly gluconolactone, are better supported for barrier improvement, hydration, tolerability, and seboregulation than for direct acne lesion reduction. Hydrogels, electrospun nanofibers, polymeric films, nanoencapsulation systems, and controlled-release platforms may improve local retention, protect volatile or irritation-prone compounds, and modulate active release at the skin surface. However, most biopolymeric platforms still rely on early-stage or indirect dermatological evidence. Overall, biopolymeric delivery systems offer a rational formulation strategy to improve the stability, tolerability, and localized action of selected acne-relevant bioactives, but their clinical translation requires standardized composition, reproducible fabrication, skin-relevant release assays, safety assessment, and controlled human studies.
Open AccessBiopolymeric Delivery Systems Enriched with Melaleuca alternifolia, Mentha piperita, and Polyhydroxy Acids for Acne Management: A Narrative Review
Acne vulgaris is a prevalent inflammatory disorder of the pilosebaceous unit involving follicular hyperkeratinization, altered sebum production, Cutibacterium acnes proliferation, microbiome imbalance, and immune activation. Although antibiotics, retinoids, benzoyl peroxide, and keratolytic agents remain central to clinical management, their long-term use may be limited by irritation, recurrence, adherence issues, and increasing antimicrobial resistance. This narrative review critically evaluates the dermatological relevance of Melaleuca alternifolia tea tree essential oil (TTEO), Mentha piperita peppermint essential oil (PPEO), and polyhydroxy acids (PHAs), as well as their incorporation into biopolymeric delivery systems for acne-oriented topical applications. Following SANRA principles, evidence from clinical, preclinical, ex vivo, and in vitro studies was synthesized, with emphasis on antimicrobial activity, inflammatory modulation, keratolytic and barrier-supportive effects, formulation stability, and release behavior. TTEO shows the strongest clinical support among the reviewed natural bioactives, including reductions in lesion counts and acne severity when applied as conventional or nanoemulsion-based formulations. PPEO is mainly supported by experimental evidence, particularly antimicrobial activity against acne-associated microorganisms, anti-inflammatory potential, and menthol-related neurocutaneous effects, whereas acne-specific clinical validation remains limited. PHAs, particularly gluconolactone, are better supported for barrier improvement, hydration, tolerability, and seboregulation than for direct acne lesion reduction. Hydrogels, electrospun nanofibers, polymeric films, nanoencapsulation systems, and controlled-release platforms may improve local retention, protect volatile or irritation-prone compounds, and modulate active release at the skin surface. However, most biopolymeric platforms still rely on early-stage or indirect dermatological evidence. Overall, biopolymeric delivery systems offer a rational formulation strategy to improve the stability, tolerability, and localized action of selected acne-relevant bioactives, but their clinical translation requires standardized composition, reproducible fabrication, skin-relevant release assays, safety assessment, and controlled human studies.